Moxifloxacin versus ethambutol in initial tuberculosis treatment

The Lancet

Volumn 373, Issue 9682, 2009, Pages 2197-2198

  Chang, Kwok Chiu ^a   Leung, Chi Chiu ^a  

^a DEPARTMENT OF HEALTH   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; MOXIFLOXACIN;

ACID FAST BACTERIUM; BACTERIUM CULTURE; CLINICAL TRIAL; HUMAN; LETTER; LUNG CAVITATION; LUNG TUBERCULOSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SPUTUM CULTURE; SPUTUM SMEAR;

EID: 67649283810     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61188-0     Document Type: Letter

References (3)

1. Conde M.B., Efron A., Loredo C., et al. Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial. Lancet 373 (2009) 1183-1189
2. Rustomjee R., Lienhardt C., Kanyok T., et al., Gatifloxacin for TB (OFLOTUB) study team. A phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. Int J Tuberc Lung Dis 12 (2008) 128-138
3. Burman W.J., Goldberg S., Johnson J.L., et al. Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis. Am J Respir Crit Care Med 174 (2006) 331-338